ArthroCAD draws Series A for surgical device development

ArthroCAD nailed down the first part of a Series A funding round to help fuel development of a surgical device meant to improve outcomes for total hip arthroplasty procedures. The company isn't disclosing financial details other than to note that it has "secured commitments for additional funding" to complete the round. A number of investors took part, including Edgar D. Jannotta Jr., a former managing partner of the Chicago private equity firm GTCR. As part of the financing, he joins the board of ArthroCAD, which is based in Ayer, MA. Release

THE LIBRARY: WEBINAR

In December 2014, FDA released the Guidance for Industry "Providing Regulatory Submissions in Electronic Format—Standardized Study Data." This webinar will review the guidance and discuss the implications for Sponsors currently conducting studies and for those starting new studies soon. Register today!